ArticleActa pharmacologica Sinica2019

Aberrant modulation of ribosomal protein S6 phosphorylation confers acquired resistance to MAPK pathway inhibitors in BRAF-mutant melanoma.

Ming-Zhao Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.